Health Care: Drugs

Synta Pharmaceuticals Inc (SNTA: NASDAQ)

$3.97 n/a | n/a%
08/21/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 0.00 147.00K 7.58M 14.80M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 147.00K 7.58M 14.80M
Selling, General, and Administrative Expenses 15.70M 11.68M 11.55M 11.45M
Research & Development 71.86M 49.41M 41.46M 40.25M
Operating Income before D & A (EBITDA) -87.56M -60.94M -45.43M -36.90M
Depreciation & Amortization 516.00K 738.00K 1.46M 1.93M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -88.08M -61.68M -46.90M -38.83M
Interest Expense 2.63M 1.85M 1.95M 569.00K
Pre-Tax Income -90.71M -63.53M -48.84M -39.40M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -90.19M -62.79M -47.38M -37.47M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -90.19M -62.79M -47.38M -37.47M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -90.19M -62.79M -47.38M -37.47M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-90.19M -62.79M -47.38M -37.47M
Preferred Dividends
Net Income Available To Common -90.19M -62.79M -47.38M -37.47M
Basic EPS from Continuing Ops. -1.27 -1.06 -1.00 -0.93
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.27 -1.06 -1.00 -0.93
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.27 -1.06 -1.00 -0.93
Basic Normalized Net Income/Share -1.27 -1.06 -1.00 -0.93
EPS fr Continuing Ops. -1.27 -1.06 -1.00 -0.93
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.27 -1.06 -1.00 -0.93
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.27 -1.06 -1.00 -0.93
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.27 -1.06 -1.00 -0.93
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SNTA

Latest SNTA Headlines from TheStreet

More Financial News for SNTA

Press Releases for SNTA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter